KalVista Pharmaceuticals, Inc. (KALV)
USD 8.46
(-2.2%)
USD 8.46
(-2.2%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -89.23 Million | -75.26 Million | -78.13 Million | -30.17 Million | -44.81 Million | -36.36 Million |
| Net Income | -126.64 Million | -92.9 Million | -82.33 Million | -46.24 Million | -29.11 Million | -20.81 Million |
| Depreciation & Amortization | 816 Thousand | 718 Thousand | 564 Thousand | 537 Thousand | 512 Thousand | 378 Thousand |
| Deferred income taxes | - | -491 Thousand | - | -42 Thousand | -33 Thousand | - |
| Stock-based compensation | 21.91 Million | 9.92 Million | 11.08 Million | 7.11 Million | 4.44 Million | 2.96 Million |
| Change in working capital | 15.16 Million | 7.41 Million | -12.32 Million | 8.34 Million | -20.64 Million | -18.79 Million |
| Other non-cash items | 10.56 Million | 84 Thousand | 4.87 Million | 114 Thousand | 13 Thousand | -103 Thousand |
| Investing Cash Flow | -84.71 Million | 41.41 Million | 57.86 Million | -147.65 Million | 16.75 Million | -69.42 Million |
| Investments in PPE | -443 Thousand | -1.19 Million | -931 Thousand | -82 Thousand | -220 Thousand | -1.08 Million |
| Acquisitions | - | -57.86 Million | -57.86 Million | 147.65 Million | -16.75 Million | 69.42 Million |
| Investment purchases | -189.23 Million | -98.24 Million | -136.92 Million | -201.21 Million | -49.79 Million | -79.88 Million |
| Sales/Maturities of investments | 104.95 Million | 140.85 Million | 195.71 Million | 53.63 Million | 66.77 Million | 11.54 Million |
| Other Investing Activities | -84.71 Million | 57.86 Million | 57.86 Million | -147.65 Million | 16.75 Million | -69.42 Million |
| Financing Cash Flow | 150.71 Million | 58.11 Million | 1.58 Million | 212.11 Million | 11.58 Million | 87.94 Million |
| Debt repayment | - | - | - | - | -54 Thousand | -209 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 150.71 Million | 56.58 Million | 1.58 Million | 210.58 Million | 11.42 Million | 87.91 Million |
| Other Financing Activities | 150.71 Million | 1.53 Million | 1581.00 | 1.53 Million | 216 Thousand | 242 Thousand |
| Accounts receivables | 8.17 Million | -2.31 Million | -5.2 Million | 7.45 Million | -5.78 Million | -4.88 Million |
| Accounts payables | 4.32 Million | 1.1 Million | 1.68 Million | 150 Thousand | -1 Million | 1.53 Million |
| Inventory | - | 2.31 Million | 5.2 Million | -7.45 Million | 5.78 Million | 4.88 Million |
| Other working capital | 2.67 Million | 6.3 Million | -14 Million | 8.19 Million | -19.63 Million | -20.32 Million |
| Cash at beginning of period | 56.23 Million | 30.73 Million | 50.59 Million | 15.78 Million | 32 Million | 51.05 Million |
| Cash at end of period | 31.78 Million | 56.23 Million | 30.73 Million | 50.59 Million | 15.78 Million | 32 Million |
| Capital Expenditure | -443 Thousand | -1.19 Million | -931 Thousand | -82 Thousand | -220 Thousand | -1.08 Million |
| Effect of forex changes on cash | -1.21 Million | 1.23 Million | -1.16 Million | 511 Thousand | 262 Thousand | -1.2 Million |
| Net cash flow / Change in cash | -24.44 Million | 25.5 Million | -19.86 Million | 34.8 Million | -16.21 Million | -19.04 Million |
| Free Cash Flow | -89.67 Million | -76.45 Million | -79.06 Million | -30.25 Million | -45.03 Million | -37.44 Million |
| Breakdown | 2024 Q4 | 2024 FY | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -44.65 Million | -126.64 Million | -29.02 Million | -27.65 Million | -25.31 Million | -92.9 Million |
| Depreciation & Amortization | 219 Thousand | 816 Thousand | 207 Thousand | 197 Thousand | 193 Thousand | 718 Thousand |
| Deferred income taxes | 6.64 Million | - | -7.17 Million | 632 Thousand | -108 Thousand | -491 Thousand |
| Stock-based compensation | 12.74 Million | 21.91 Million | 2.71 Million | 3.2 Million | 3.25 Million | 9.92 Million |
| Change in working capital | 16.61 Million | 15.16 Million | -1.03 Million | 3.8 Million | -4.21 Million | 7.41 Million |
| Other non-cash items | -7.33 Million | 10.56 Million | 6.74 Million | -19 Thousand | -533 Thousand | 84 Thousand |
| Investing Cash Flow | -126.18 Million | -84.71 Million | -6.7 Million | 28.55 Million | 19.61 Million | 41.41 Million |
| Investments in PPE | -416 Thousand | -443 Thousand | -19 Thousand | -205 Thousand | -6000.00 | -1.19 Million |
| Acquisitions | 105 Thousand | - | - | 203 Thousand | -308 Thousand | -57.86 Million |
| Investment purchases | -141.54 Million | -189.23 Million | -18.15 Million | -3.77 Million | -25.76 Million | -98.24 Million |
| Sales/Maturities of investments | 15.48 Million | 104.95 Million | 11.55 Million | 32.53 Million | 45.38 Million | 140.85 Million |
| Other Investing Activities | 294 Thousand | -84.71 Million | -91 Thousand | -203 Thousand | 308 Thousand | 57.86 Million |
| Financing Cash Flow | 150.09 Million | 150.71 Million | 284 Thousand | 128 Thousand | 204 Thousand | 58.11 Million |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 150.09 Million | 150.71 Million | 284 Thousand | 128 Thousand | 204 Thousand | 56.58 Million |
| Other Financing Activities | 150.71 Million | 150.71 Million | 284.00 | 128.00 | 204.00 | 1.53 Million |
| Accounts receivables | 14.39 Million | 8.17 Million | -2.1 Million | -2.02 Million | -2.08 Million | -2.31 Million |
| Accounts payables | 6.09 Million | 4.32 Million | -1.94 Million | 55 Thousand | 108 Thousand | 1.1 Million |
| Inventory | 110 Thousand | - | - | 2.02 Million | -2.13 Million | 2.31 Million |
| Other working capital | -3.87 Million | 2.67 Million | 3.01 Million | 3.75 Million | -108 Thousand | 6.3 Million |
| Cash at beginning of period | 23.05 Million | 56.23 Million | 57.66 Million | 49.4 Million | 56.23 Million | 30.73 Million |
| Cash at end of period | 31.78 Million | 31.78 Million | 23.05 Million | 57.66 Million | 49.4 Million | 56.23 Million |
| Capital Expenditure | -416 Thousand | -443 Thousand | -19 Thousand | -205 Thousand | -6000.00 | -1.19 Million |
| Effect of forex changes on cash | -74 Thousand | -1.21 Million | -621 Thousand | -602 Thousand | 84 Thousand | 1.23 Million |
| Net cash flow / Change in cash | 8.73 Million | -24.44 Million | -34.61 Million | 8.25 Million | -6.82 Million | 25.5 Million |
| Free Cash Flow | -15.52 Million | -89.67 Million | -27.59 Million | -20.03 Million | -26.73 Million | -76.45 Million |
6973
NTAR
6882
600704
0NFS
600176